Progression patterns and site‐specific responses in advanced gastric cancer patients treated with nivolumab

Abstract Background While the efficacy of immune checkpoint inhibitors (ICIs) reportedly varies among metastatic sites and progression patterns (classified as systemic progression [SP] or mixed progression [MP]), the clinical efficacy of ICIs against gastric cancer remains unclear. The response to n...

全面介绍

书目详细资料

发表在:	Cancer Medicine
Main Authors:	Toru Kadono, Satoru Iwasa, Kengo Nagashima, Kotoe Oshima, Shun Yamamoto, Hidekazu Hirano, Natsuko Okita, Hirokazu Shoji, Yoshitaka Honma, Atsuo Takashima, Ken Kato, Toshikazu Ushijima, Narikazu Boku
格式:	文件
语言:	英语
出版:	Wiley 2023-04-01
主题:	gastric cancer immune checkpoint inhibitors multivariate analysis nivolumab prognosis
在线阅读:	https://doi.org/10.1002/cam4.5689